Legis Daily

Disease X Act of 2023

USA118th CongressHR-3832| House 
| Updated: 6/9/2023
Lori Trahan

Lori Trahan

Democratic Representative

Massachusetts

Cosponsors (5)
Michael C. Burgess (Republican)Mike Garcia (Republican)Dan Crenshaw (Republican)Lizzie Fletcher (Democratic)Susie Lee (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Disease X Act of 2023 This bill expands the priorities of the Biomedical Advanced Research and Development Authority (BARDA) to specifically include viral threats that have the potential to cause a pandemic. In particular, the bill expands the scope of innovation grants and contracts that may be awarded by BARDA to specifically include those that support research and development of certain manufacturing technology for medical countermeasures against viruses, including respiratory viruses, with pandemic potential. It also expands BARDA's authorized strategic initiatives to include advanced research, development, and procurement of countermeasures and products to address viruses with pandemic potential.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 5, 2023
Introduced in House
Jun 5, 2023
Referred to the House Committee on Energy and Commerce.
Jun 9, 2023
Referred to the Subcommittee on Health.
Jun 21, 2023

Latest Companion Bill Action

S 118-2093
Introduced in Senate
  • June 5, 2023
    Introduced in House


  • June 5, 2023
    Referred to the House Committee on Energy and Commerce.


  • June 9, 2023
    Referred to the Subcommittee on Health.


  • June 21, 2023

    Latest Companion Bill Action

    S 118-2093
    Introduced in Senate

Health

Related Bills

  • HR 118-4421: Preparing for All Hazards and Pathogens Reauthorization Act
  • S 118-2093: Disease X Act of 2023
  • HR 118-4697: Protecting PAHPA Act of 2023
Advanced technology and technological innovationsInfectious and parasitic diseasesMedical researchResearch administration and fundingResearch and development

Disease X Act of 2023

USA118th CongressHR-3832| House 
| Updated: 6/9/2023
Disease X Act of 2023 This bill expands the priorities of the Biomedical Advanced Research and Development Authority (BARDA) to specifically include viral threats that have the potential to cause a pandemic. In particular, the bill expands the scope of innovation grants and contracts that may be awarded by BARDA to specifically include those that support research and development of certain manufacturing technology for medical countermeasures against viruses, including respiratory viruses, with pandemic potential. It also expands BARDA's authorized strategic initiatives to include advanced research, development, and procurement of countermeasures and products to address viruses with pandemic potential.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 5, 2023
Introduced in House
Jun 5, 2023
Referred to the House Committee on Energy and Commerce.
Jun 9, 2023
Referred to the Subcommittee on Health.
Jun 21, 2023

Latest Companion Bill Action

S 118-2093
Introduced in Senate
  • June 5, 2023
    Introduced in House


  • June 5, 2023
    Referred to the House Committee on Energy and Commerce.


  • June 9, 2023
    Referred to the Subcommittee on Health.


  • June 21, 2023

    Latest Companion Bill Action

    S 118-2093
    Introduced in Senate
Lori Trahan

Lori Trahan

Democratic Representative

Massachusetts

Cosponsors (5)
Michael C. Burgess (Republican)Mike Garcia (Republican)Dan Crenshaw (Republican)Lizzie Fletcher (Democratic)Susie Lee (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • HR 118-4421: Preparing for All Hazards and Pathogens Reauthorization Act
  • S 118-2093: Disease X Act of 2023
  • HR 118-4697: Protecting PAHPA Act of 2023
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Advanced technology and technological innovationsInfectious and parasitic diseasesMedical researchResearch administration and fundingResearch and development